Browse > Article
http://dx.doi.org/10.22671/JKADA.2021.9.1.61

Oral bacterium Porphyromonas gingivalis, an upstream driver of dementia  

Kim, Hyesung (Apple Tree Institute of Biomedical Science, Apple Tree Medical Foundation)
Hwang, Inseong (Docsmedi Corp.)
Publication Information
Journal of Korean Academy of Dental Administration / v.9, no.1, 2021 , pp. 61-64 More about this Journal
Keywords
Citations & Related Records
연도 인용수 순위
  • Reference
1 Dominy SS, Lynch C, Ermini F, Benedyk M, Marczyk A, Konradi A, et al. Porphyromonas gingivalis in Alzheimer's disease brains: evidence for disease causation and treatment with small-molecule inhibitors. Sci Adv 2019;5(1):eaau3333.   DOI
2 Hardy J, Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol Sci 1991;12(10):383-8.   DOI
3 de Oliveira Araujo R, Villoria GEM, Luiz RR, Esteves JC, Leao ATT, Feres-Filho EJ. Association between periodontitis and Alzheimer's disease and its impact on the self-perceived oral health status: a case-control study. Clin Oral Investig 2021;25(2):555-62.   DOI
4 Gosztyla ML, Brothers HM, Robinson SR. Alzheimer's amyloid-β is an antimicrobial peptide: a review of the evidence. J Alzheimers Dis 2018;62(4):1495-506.   DOI
5 Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT. Inflammation as a central mechanism in Alzheimer's disease. Alzheimers Dement (NY) 2018;4:575-90.   DOI
6 van de Guchte M, Blottiere HM, Dore J. Humans as holobionts: implications for prevention and therapy. Microbiome 2018;6(1):81.   DOI
7 Kumar DK, Choi SH, Washicosky KJ, Eimer WA, Tucker S, Ghofrani J, et al. Amyloid-b peptide protects against microbial infection in mouse and worm models of Alzheimer's disease. Sci Transl Med 2016;8(340):340ra72.   DOI
8 Narengaowa, Kong W, Lan F, Awan UF, Qing H, Ni J. The oral-gut-brain AXIS: the influence of microbes in Alzheimer's disease. Front Cell Neurosci 2021;15:633735.   DOI
9 Vigasova D, Nemergut M, Liskova B, Damborsky J. Multi-pathogen infections and Alzheimer's disease. Microb Cell Fact 2021;20(1):25.   DOI
10 Hussain B, Fang C, Chang J. Blood-brain barrier breakdown: an emerging biomarker of cognitive impairment in normal aging and dementia. Front Neurosci 2021;15:688090.   DOI
11 de Oliveira J, Kucharska E, Garcez ML, Rodrigues MS, Quevedo J, Moreno-Gonzalez I, et al. Inflammatory cascade in Alzheimer's disease pathogenesis: a review of experimental findings. Cells 2021;10(10):2581.   DOI
12 Willis JR, Gabaldon T. The human oral microbiome in health and disease: from sequences to ecosystems. Microorganisms 2020;8(2):308.   DOI
13 Carter CJ, France J, Crean S, Singhrao SK. The Porphyromonas gingivalis/host interactome shows enrichment in GWASdb genes related to Alzheimer's disease, diabetes and cardiovascular diseases. Front Aging Neurosci 2017;9:408.   DOI
14 Choi S, Kim K, Chang J, Kim SM, Kim SJ, Cho HJ, et al. Association of chronic periodontitis on Alzheimer's disease or vascular dementia. J Am Geriatr Soc 2019;67(6):1234-9.   DOI